MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Subjective Cognitive Complaints in early Parkinson’s Disease patients with normal cognition are associated with affective symptoms

    C.Y Chua, M.E Koh, N.Y Chia, S.E Ng, S.E Saffari, M.C Wen, R.Y Chen, X. Choi, D.L Heng, S.X Neo, K.Y Tay, W.L Au, E.K Tan, L.S Tan, Z. Xu (Singapore, Singapore)

    Objective: To determine the prevalence of Subjective Cognitive Complaints (SCC) in early Parkinson’s disease (PD) and examine the correlates between SCC in early PD and…
  • MDS Virtual Congress 2020

    Alexithymia, Depression, and Cognition in Patients with Parkinson’s disease

    G. Kenangil, M. Demir, E. Tur, F. Domaç (Istanbul, Turkey)

    Objective: The aim of our study is to examine the relation of alexithymia with cognition and depression in non-demented patients with Parkinson's disease (PD). Background:…
  • MDS Virtual Congress 2020

    Parkinson’s Disease Clinical Subtypes: Symptom Progression, Dementia, and Mortality

    P. Myers, J. Jackson, A. Clover, C. Lessov-Schlaggar, E. Foster, J. Perlmutter, M. Campbell (St. Louis, MO, USA)

    Objective: Identify Parkinson's disease (PD) clinical subtypes using multi-domain classification; determine subtype symptom progression; assess subtype clinical utility. Background: People with PD present with combinations…
  • MDS Virtual Congress 2020

    Investigating Factors Contributing to Parkinson’s disease-related Cognitive Decline

    P. Tipton, N. Bulbul, J. Crook, O. Ross, Z. Wszolek, N. Ertekin-taner (Jacksonville, FL, USA)

    Objective: The objective of this study was to identify predictive factors of cognitive decline in patients with Parkinson’s disease (PD). Background: Among those with PD,…
  • MDS Virtual Congress 2020

    Nucleus basalis of Meynert free-water distinguishes and predicts cognitive impairment and longitudinally correlates with cognitive changes in early Parkinson’s disease

    T. Guttuso, Jr., D. Tosun, R. Zivadinov, O. Pasternak, D. Weintraub, N. Bergsland (Buffalo, NY, USA)

    Objective: To explore diffusion-based MRI assessments of the nucleus basalis of Meynert (nbM) as a neuroimaging biomarker of cognitive abilities and longitudinal cognitive changes in…
  • MDS Virtual Congress 2020

    Is the Montreal Cognitive Assessment (MoCA) Suitable for Identifying Mild Cognitive Impairment in Parkinson’s Disease?

    S. Hassin-Baer, S. Meyer, N. Gemerman, L. Mentzer, S. Israeli-Korn, A. Richardson, V. Livneh, T. Fay Karmon, T. Nevo, H. Strauss, G. Yahalom, S. Rosenblum (Ramat-Gan, Israel)

    Objective: To explore neuropsychological test scores of Parkinson’s disease (PD) patients who were categorized based on their Montreal Cognitive Assessment (MoCA) scores as having mild…
  • 2019 International Congress

    GBA mutation: Linking Parkinson’s and Gaucher’s Diseases

    C. Sarabia-Tapia, S. Lopez-Alamillo, N. Monroy-Jaramillo, D. Davila-Ortiz, M. Rodriguez-Violante, A. Cervantes-Arriaga (Mexico City, Mexico)

    Objective: Identify among patients attending the Movement Disorders Unit at the National Institute of Neurology and Neurosurgery, Mexico, if glucocerebrosidase (GBA) mutations were present in…
  • 2019 International Congress

    Serum uric acid levels and cognitive function in Parkinson’s disease

    J. Difrancisco-Donoghue, W. Werner, B. Krishnamachari, K. Arabian, E. Thomas, D. Granger, R. Gallagher (Irvine, CA, USA)

    Objective: To compare serum uric acid (sUA) levels in Parkinson’s disease (PD) subjects to cognitive function. Background: Reduced sUA levels have been reported in individuals…
  • 2019 International Congress

    Resting-state EEG functional connectivity in Parkinson’s disease

    R. Shoorangiz, E. Peterson, R. Jones, L. Livingston, I. Kirk, L. Tippett, M. Livingstone, T. Anderson, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To examine EEG functional connectivity (FC) between brain regions during resting wakefulness as a function of cognitive status in PD. Background: Progressive cognitive decline…
  • 2019 International Congress

    Apathy and cognitive profile in Parkinson´s disease: A cross-sectional study in Cali-Colombia

    B. Muñoz, J. Valderrama, L. Botero, J. Orozco (Cali, Colombia)

    Objective: To describe and correlate the apathy and cognitive profile of patients with Parkinson’s disease (PD). Background: Prevalence of apathy in PD is highly variable…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley